Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 92 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 7176208

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 13, 2007 · Expires Feb 8, 2027

    granted
  2. US 7173039

    Protein kinase inhibitors

    Theravance, Inc. · Granted Feb 6, 2007 · Expires Feb 1, 2027

    granted
  3. US 7169798

    Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2007 · Expires Jan 25, 2027

    granted
  4. US 7169801

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jan 30, 2007 · Expires Jan 25, 2027

    granted
  5. US 7169800

    Imidazole compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2007 · Expires Jan 25, 2027

    granted
  6. US 7169779

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2007 · Expires Jan 25, 2027

    granted
  7. US 7166619

    Prenylation inhibitors and methods of their synthesis and use

    PPD Discovery, Inc. · Granted Jan 23, 2007 · Expires Jan 18, 2027

    granted
  8. US 7161003

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 9, 2007 · Expires Jan 4, 2027

    granted
  9. US 7157476

    Aminofurazan compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 2, 2007 · Expires Dec 28, 2026

    granted
  10. US 7151101

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  11. US 7132392

    Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  12. US 7132420

    Aspartic protease inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  13. US 7125845

    Aza-peptide macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  14. US 7122552

    Inhibitors of JAK and CDK2 protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  15. US 7119200

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  16. US 7119105

    Methods for treating neurodegenerative disorders using aspartyl protease inhibitors

    The Regents of the University of California · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  17. US 7115739

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  18. US 7115637

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  19. US 7109172

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 19, 2006 · Expires Sep 14, 2026

    granted
  20. US 7098216

    Thiazolopyrimidines useful as TNFα inhibitors

    The Regents of the University of California · Granted Aug 29, 2006 · Expires Aug 24, 2026

    granted
  21. US 7098330

    Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 29, 2006 · Expires Aug 24, 2026

    granted
  22. US 7091343

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 15, 2006 · Expires Aug 10, 2026

    granted
  23. US 7087603

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 8, 2006 · Expires Aug 3, 2026

    granted
  24. US 7087642

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Aug 8, 2006 · Expires Aug 3, 2026

    granted